Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 001333.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -8.68 2.43 2.67
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 92.15 -1.08 -13.78
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.49 12.55 12.37
Cash 19.91 5.58 4.65
Capex -575.95 -0.24 -0.04
Free Cash Flow -254.77 -0.75 -0.21
Revenue -4.46 2.77 2.90
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 8.41 0.15 0.13
Operating Margin 84.61 0.08 0.04
ROA 84.38 0.01 < 0.005
ROE 92.71 0.02 < 0.005
ROIC 36.00 0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 001333.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 001333.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 001333.SZ is permitted for members.